Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Finance

BioNTech says Novartis executive Zapata-Gomez to become CFO

Published by Global Banking & Finance Review

Posted on May 5, 2025

1 min read

· Last updated: January 24, 2026

Add as preferred source on Google

BioNTech says Novartis executive Zapata-Gomez to become CFO

Global Banking & Finance Awards 2026 — Call for Entries

BioNTech Names Novartis Executive as New CFO

(Reuters) - German COVID-19 vaccine maker BioNTech said on Monday that Ramon Zapata-Gomez will become its new finance chief from July 1.

Zapata-Gomez is currently CFO of Novartis unit Novartis BioMedical Research and will take over from Jens Holstein who, as previously announced, will retire from BioNTech on June 30.

(Reporting by Isabel Demetz and Ludwig Burger)

Key Takeaways

Ramon Zapata-Gomez appointed as BioNTech's CFO.
Zapata-Gomez is currently CFO at Novartis BioMedical Research.
Jens Holstein to retire from BioNTech on June 30.
Leadership change effective from July 1.
BioNTech continues to strengthen its executive team.

Frequently Asked Questions

What is the main topic?

The main topic is the appointment of Ramon Zapata-Gomez as the new CFO of BioNTech, succeeding Jens Holstein.

Who is the new CFO of BioNTech?

Ramon Zapata-Gomez, currently CFO at Novartis BioMedical Research, will become BioNTech's new CFO.

When will the leadership change take effect?

The leadership change will take effect on July 1, following Jens Holstein's retirement on June 30.

QIC Digital Hub Recognised as Best Place to Work Qatar 2026 at the 2026 Global Banking & Finance Review Awards®

PRIMA FINANTARE Named Best New SME Finance Company Romania 2026 at the 2026 Global Banking & Finance Review Awards®

Britain's financial regulator consults on changes to IPO research

Two months into Iran war, economic strain mounts across emerging markets

Del Vecchio heirs approve $12 billion buyout of two siblings, source says

Romania's largest party teams up with far-right opposition to topple pro-European coalition

More from Finance

Explore more articles in the Finance category

Polish nine-day charity stream breaks records to support kids with cancer

EU extends sanctions against Myanmar by a year

Bridgepoint agrees to buy most of German identity security firm iC Consult from Carlyle

CSG to launch Azerbaijan defence venture worth 'hundreds of millions of euros'

FTSE 100 edges higher as energy, banking stocks power gains

Russian Finance Minister warns of regional budgets' strains, rising debt

UK retail sales tumble by most in over 40 years, CBI survey shows

German foreign minister: we need deterrence in face of nuclear threats

Zaporizhzhia nuclear power plant worker killed in Ukraine drone attack, management says

Analysis-Iran war fertiliser squeeze could spell trouble for next year's grain harvests

UK PM Starmer to discuss Iran war impact with Bank of England

Chinese battery maker CATL launches $5 billion Hong Kong shares offering, term sheet shows

View All Finance Posts